Click on one of these terms to refine your search
1 to 10 of 24 literature results
Maropitant (Cerenia), a selective neurokinin(1) receptor antagonist, was evaluated for efficacy and safety in prevention of vomiting due to motion sic…
Authors: G A Conder, H S Sedlacek, J F Boucher, R G Clemence
Source: Journal of veterinary pharmacology and therapeutics. 2008 Dec
View Full TextThis study investigated the associations of both bacteriological cure and quarter somatic cell count (SCC) after intramammary antibiotic treatment wit…
Authors: H A Deluyker, S N Van Oye, J F Boucher
Source: Journal of dairy science. 2005 Feb
View Full TextMaropitant (Cerenia), a selective neurokinin(1) receptor antagonist, was evaluated for safety and efficacy in treatment and prevention of acute vomiti…
Authors: D S Ramsey, K Kincaid, J A Watkins, J F Boucher, G A Conder, J S Eagleson, R G Clemence
Source: Journal of veterinary pharmacology and therapeutics. 2008 Dec
View Full TextThe objectives of this study were to evaluate the effects of dirlotapide, a microsomal triglyceride transfer protein inhibitor, on apparent nutrient d…
Authors: C A Kirk, J F Boucher, S J Sunderland, J A Wren
Source: Journal of veterinary pharmacology and therapeutics. 2007 Aug
View Full TextMaropitant (Cerenia; a novel, selective neurokinin(1) receptor antagonist), chlorpromazine, metoclopramide and ondansetron were compared in two random…
Authors: H S Sedlacek, D S Ramsey, J F Boucher, J S Eagleson, G A Conder, R G Clemence
Source: Journal of veterinary pharmacology and therapeutics. 2008 Dec
View Full TextThe pharmacokinetic properties of cefpodoxime, and its prodrug, cefpodoxime proxetil, were evaluated in two separate studies, one following intravenou…
Authors: S A Brown, J F Boucher, V L Hubbard, M J Prough, T F Flook
Source: Journal of veterinary pharmacology and therapeutics. 2007 Aug
View Full TextMaropitant is the first NK1 receptor antagonist developed to treat and prevent emesis in dogs; it is administered by subcutaneous (s.c.) injection at …
Authors: H A Benchaoui, S R Cox, R P Schneider, J F Boucher, R G Clemence
Source: Journal of veterinary pharmacology and therapeutics. 2007 Aug
View Full TextAn intravaginal progesterone insert (CIDR insert; 1.38 g of progesterone) was evaluated for synchronization of returns to estrus (SR), conception rate…
Authors: J R Chenault, J F Boucher, K J Dame, J A Meyer, S L Wood-Follis
Source: Journal of dairy science. 2003 Jun
View Full TextMilk from pregnant cows contains concentrations of progesterone (P4) considered safe for human consumption. The objective of this study was to determi…
Authors: J R Chenault, R E Hornish, Y C Anderson, L F Krabill, J F Boucher, M J Prough
Source: Journal of dairy science. 2003 Jun
View Full TextThe dose response of melengestrol acetate (MGA) on ADG (kg/d) and gain efficiency (gain/DMI, g/kg) was estimated in beef steers fed a finishing diet u…
Authors: W M Moseley, D M Meeuwse, J F Boucher, K J Dame, J W Lauderdale
Source: Journal of animal science. 2003 Nov
View Full Text